Publications by authors named "Joseph Manetta"

Claim this Profile
D
Development of tibulizumab, a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune disease.
Robert J Benschop, Chi-Kin Chow, Yu Tian, James Nelson, Barbra Barmettler, Joseph Manetta

MAbs· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maternal Serum B-Cell Activating Factor Levels: Candidate Early Biomarker for Hypertensive Disorders of Pregnancy.
Hindi E Stohl, Richard H Lee, Joseph Manetta, Kristine Kikly, Lisa M Korst

Hypertension· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation and characterization of tabalumab, a human monoclonal antibody that neutralizes both soluble and membrane-bound B-cell activating factor.
Joseph Manetta, Holly Bina, Paul Ryan, Niles Fox, Derrick R Witcher

J Inflamm Res· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A dual-monoclonal sandwich ELISA specific for hepcidin-25.
Anthony M Butterfield, Peng Luan, Derrick R Witcher, Joseph Manetta, Anthony T Murphy

Clin Chem· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, metabolic stability, and subcutaneous bioavailability of a genetically engineered analog of DcR3, FLINT [DcR3(R218Q)], in cynomolgus monkeys and mice.
Victor J Wroblewski, Christy McCloud, Kelly Davis, Joseph Manetta, Radmila Micanovic

Drug Metab Dispos· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis